Info
Insider Trading

Insider Transactions Reported by 15 Insiders of Checkmate Pharmaceuticals, Inc.

Location: Cambridge, MA

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

Checkmate Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Novo Holdings A/S	10%+ Owner	$22,592,579			23 Feb 2022
venBio Global Strategic Fund II L.P.	10%+ Owner	$22,529,253			13 May 2022
Arthur M. Krieg	Chief Scientific Officer	$8,524,339			18 Jun 2021
Flaherty Keith T.	Director				31 May 2022
Peter Colabuono	Director				31 May 2022
Oren Isacoff	Director				31 May 2022
Kleem Chaudhary	Chief Business Officer				04 Aug 2021
James Wooldridge	Chief Medical Officer				31 May 2022
Robert Dolski	Chief Financial Officer				31 May 2022
Joy Yan	Director				31 May 2022
Alan Bash	Chief Executive Officer, Director				31 May 2022
Michael Powell	Director				31 May 2022
Barry Labinger	President and CEO, Director				04 Aug 2021
Alan Fuhrman	Director				31 May 2022
Jon Marc Wigginton	Director				31 May 2022

Recent Insider Transactions by Companies or Individuals for Checkmate Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
No insider transactions were found in the last 12 months for this issuer.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.